Dr. Shelby

Shelby Shelby is a versatile professional in the field of biosciences with a rich academic background and extensive experience in various organizations.

Shelby holds a Doctor of Philosophy - PhD in Plant Sciences and a Master of Philosophy - MPhil in Bioscience Enterprise from the prestigious University of Cambridge. The academic journey also includes a Bachelor's Degree in Biochemistry with an Engineering Sciences Minor from The Ohio State University.

Shelby has been actively involved in the investment sector, currently serving as an Investor at Compound. Previously, Shelby has contributed as an Analyst at Hummingbird Ventures and held internships at Ahren Innovation Capital and Picus Capital. Shelby's expertise extends to due diligence projects as the former Team Lead at Start Codon.

An accomplished leader, Shelby has founded and presided over various societies and clubs, such as the Newnham College Finance and Investment Society and the Cambridge University Venture Capital and Private Equity Society. Shelby's engagement with the Global Biotech Revolution as a Leader of Tomorrow showcases a commitment to fostering innovation in the biotechnology sector.

Prior to venturing into investments, Shelby's research experience is extensive. Shelby has served as a PhD Candidate in Plant Science at the University of Cambridge, conducted consultancy work at the Cambridge Consulting Network, and participated in foresight and scouting activities at Merck Group. Research roles at esteemed institutions like The National Institutes of Health and Helmholtz Centre for Infection Research are significant highlights in Shelby's career, emphasizing a strong research background.

Shelby's academic acumen is complemented by practical teaching experience, having served as an Organic Chemistry Laboratory Teaching Assistant at The Ohio State University. Research assistant roles at The Ohio State University in labs like Serpe Lab and Glaser Lab further demonstrate Shelby's hands-on approach to scientific exploration.